Evidence map›Paper›PMID 30050295›Full record

ArticleInternational journal of chronic obstructive pulmonary disease2018

The COPDnet integrated care model.

Eleonore H Koolen, Philip J van der Wees, Gert P Westert, Richard Dekhuijzen, Yvonne F Heijdra, Alex J van 't Hul

Abstract read
In one paragraph

Article in International journal of chronic obstructive pulmonary disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Exploring community members' perceptions to adopt a Tele-COPD program in rural counties.Exploratory research in clinical and social pharmacy · 2021
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Evaluation of the COPDnet integrated care model in patients with COPD: the study protocol.International journal of chronic obstructive pulmonary disease · 2018
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Eleonore H KoolenDepartment of Pulmonary Diseases, Radboud University Medical Center, Nijmegen, the Netherlands, noortje.koolen@radboudumc.nl.
Philip J van der WeesRadboud Institute for Health Sciences, IQ Healthcare, Radboud University Medical Center, Nijmegen, the Netherlands.
Gert P WestertRadboud Institute for Health Sciences, IQ Healthcare, Radboud University Medical Center, Nijmegen, the Netherlands.
Richard DekhuijzenDepartment of Pulmonary Diseases, Radboud University Medical Center, Nijmegen, the Netherlands, noortje.koolen@radboudumc.nl.
Yvonne F HeijdraDepartment of Pulmonary Diseases, Radboud University Medical Center, Nijmegen, the Netherlands, noortje.koolen@radboudumc.nl.
Alex J van 't HulDepartment of Pulmonary Diseases, Radboud University Medical Center, Nijmegen, the Netherlands, noortje.koolen@radboudumc.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: This research project sets out to design an integrated disease management model for patients with COPD who were referred to a secondary care setting and who qualified for pharmacological and nonpharmacological intervention options. Theory and methods: The integrated disease management model was designed according to the guidelines of the European Pathway Association and the content founded on the Chronic Care Model, principles of integrated disease management, and knowledge of quality management systems. Results: An integrated disease management model was created, and comprises 1) a diagnostic trajectory in a secondary care setting, 2) a nonmedical intervention program in a primary care setting, and 3) a pulmonary rehabilitation service in a tertiary care setting. The model also includes a quality management system and regional agreements about exacerbation management and palliative care. Discussion: In the next phase of the project, the COPDnet model will be implemented in at least two different regions, in order to assess the added value of the entire model and its components, in terms of feasibility, health status benefits, and costs of care. Conclusion: Based on scientific theories and models, a new integrated disease management model was developed for COPD patients, named COPDnet. Once the model is stable, it will be evaluated for its feasibility, health status benefits, and costs.

Indexed as

Disease ManagementCost of IllnessDecision Support TechniquesDelivery of Health Care, IntegratedDisease ProgressionHumansModels, TheoreticalPalliative CarePrimary Health CarePulmonary Disease, Chronic ObstructiveQuality of Health CareQuality of LifeResearch DesignSecondary Care CentersChronic Care ModelCOPDCOPD managementhealth statusintegrated care

Identifiers

PMID30050295
PMCPMC6056161

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.